Hydroxyprostaglandin Dehydrogenase 15-(NAD) (HPGD) Peptid
Kurzübersicht für Hydroxyprostaglandin Dehydrogenase 15-(NAD) (HPGD) Peptid (ABIN936298)
Target
Spezies
Quelle
Applikation
-
-
Protein-Typ
- Synthetic
-
Sequenz
- DQQQLRDTFR KVVDHFGRLD ILVNNAGVNN EKNWEKTLQI NLVSVISGTY
-
Produktmerkmale
-
A synthetic peptide for use as a blocking control in assays to test for specificity of HPGD antibody,
Alternative Names: HPGD control peptide, HPGD antibody Blocking Peptide, Anti-HPGD Blocking Peptide, hydroxyprostaglandin dehydrogenase 15-(NAD Blocking Peptide, Blocking Peptide, PGDH Blocking Peptide, PGDH1 Blocking Peptide, SDR36C1 Blocking Peptide -
Aufreinigung
- Immunoaffinity purification
-
-
-
-
Applikationshinweise
- Optimal conditions should be determined by the investigator
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
-
Buffer
- PBS
-
Handhabung
- Avoid repeated freeze/thaw cycles.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20 °C long term.
-
-
- HPGD (Hydroxyprostaglandin Dehydrogenase 15-(NAD) (HPGD))
-
Hintergrund
- This gene encodes a member of the short-chain nonmetalloenzyme alcohol dehydrogenase protein family. The encoded enzyme is responsible for the metabolism of prostaglandins, which function in a variety of physiologic and cellular processes such as inflammation. Mutations in this gene result in primary autosomal recessive hypertrophic osteoarthropathy and cranioosteoarthropathy. Multiple transcript variants encoding different isoforms have been found for this gene.
-
Molekulargewicht
- 29 kDa
Target
-